A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low rates of side effects for people ...
According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved ...
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Among younger men with prostate ...
Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...
Intensity-modulated proton therapy (IMPT) matched intensity-modulated radiation therapy (IMRT) for progression-free survival in a phase III trial of oropharyngeal cancer. Patients receiving proton ...
People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy - proton beam therapy or intensity modulated radiation therapy (IMRT) - ...
In a phase 3 trial of patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) resulted in noninferior progression-free survival and better overall survival than ...
SAN FRANCISCO -- Treatment with intensity-modulated proton therapy (IMPT) or intensity-modulated radiation therapy (IMRT) resulted in similarly low rates of late toxicity in patients with locally ...
Mission Complete: Mevion Medical Systems to showcase the MEVION S250-FIT Proton Therapy System TM, a revolutionary patient-centric proton therapy solution designed to FIT in a conventional LINAC vault ...
SAN FRANCISCO, September 29, 2025 — A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low ...
According to preliminary data from a multi-institution Phase III trial intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results